The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.
Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase
Open accessAbstract
The ATR-Chk1 pathway is critical for DNA damage responses and cell-cycle progression. Chk1 inhibition is more deleterious to cycling cells than ATR inhibition, raising questions about ATR and Chk1 functions in the absence of extrinsic replication stress. Here we show that a key role of ATR in S phase is to coordinate RRM2 accumulation and origin firing. ATR inhibitor (ATRi) induces massive ssDNA accumulation and replication catastrophe in a fraction of early S-phase cells. In other S-phase cells, however, ATRi induces moderate ssDNA and triggers a DNA-PK and Chk1-mediated backup pathway to suppress origin firing. The backup pathway creates a threshold such that ATRi selectively kills cells under high replication stress, whereas Chk1 inhibitor induces cell death at a lower threshold. The levels of ATRi-induced ssDNA correlate with ATRi sensitivity in a panel of cell lines, suggesting that ATRi-induced ssDNA could be predictive of ATRi sensitivity in cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
Self-citationDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Causes and consequences of replication stress
Zeman, M. K., & Cimprich, K. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2897 · Cited by 2,079
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Flagged first, then by citations
2 of the 72 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 318
Ditano, J. P., Donahue, K. L., Tafe, L. J., McCleery, C. F., & Eastman, A. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-86490-x · Cited by 13
LAP2α preserves genome integrity through assisting RPA deposition on damaged chromatin
Bao, K., Zhang, Q., Liu, S., Song, N., Guo, Q., Liu, L., Tian, S., Hao, J., Zhu, Y., Zhang, K., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02638-6 · Cited by 13
Soni, A., Duan, X., Stuschke, M., & Iliakis, G. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147506 · Cited by 13
Dearth and Delayed Maturation of Testicular Germ Cells in Fanconi Anemia E Mutant Male Mice
Fu, C. M., Begum, K., Jordan, P. W., He, Y., & Overbeek, P. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159800 · Cited by 13
Knockdown of RMI1 impairs DNA repair under DNA replication stress
Xu, C., Fang, L., Kong, Y., Xiao, C., Yang, M., Du, L., & Liu, Q. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.062 · Cited by 13
Claspin: From replication stress and DNA damage responses to cancer therapy
Azenha, D., Lopes, M. C., & Martins, T. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.10.007 · Cited by 13
Federico, M. B., Siri, S. O., Calzetta, N. L., Paviolo, N. S., de la Vega, M. B., Martino, J., Campana, M. C., Wiesmüller, L., & Gottifredi, V. (2020) · Oncogene · doi:10.1038/s41388-020-1265-9 · Cited by 12
Cote, G. M., Kochupurakkal, B. S., Do, K. T., Bullock, A. J., Cheng, M. L., Muzikansky, A., McLoughlin, D. E., Cleary, J. M., Gao, X., Parikh, A. R., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1867 · Cited by 12
Self-citationMurray, C. E., Kornepati, A. V. R., Ontiveros, C. O., Liao, Y., Avalos, B. D. L. P., Rogers, C. M., Liu, Z., Deng, Y., Bai, H., Kari, S., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02147-z · Cited by 11
Bittmann, J., Grigaitis, R., Galanti, L., Amarell, S., Wilfling, F., Matos, J., & Pfander, B. (2020) · eLife · doi:10.7554/elife.52459 · Cited by 12
Intrinsic ATR signaling shapes DNA end resection and suppresses toxic DNA-PKcs signaling
Dibitetto, D., Sims, J. R., Ascenção, C. F. R., Feng, K., Kim, D.-S., Oberly, S., Freire, R., & Smolka, M. B. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa006 · Cited by 13
Vitorino, F. N. D. L., Montoni, F., Moreno, J. N., de Souza, B. F., Lopes, M. D. C., Cordeiro, B., Fonseca, C. S., Gilmore, J., Sardiu, M., Reis, M. S., et al. (2018) · Proteomics · doi:10.1002/pmic.201800203 · Cited by 7
CHK1 inhibition exacerbates replication stress induced by IGF blockade
Wu, X., Seraia, E., Hatch, S. B., Wan, X., Ebner, D. V., Aroldi, F., Jiang, Y., Ryan, A. J., Bogenrieder, T., Weyer-Czernilofsky, U., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02080-1 · Cited by 12
Evangelisti, G., Barra, F., Moioli, M., Sala, P., Stigliani, S., Gustavino, C., Costantini, S., & Ferrero, S. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1783238 · Cited by 12
Adefovir dipivoxil induces DNA replication stress and augments ATR inhibitor‐related cytotoxicity
Patel, A., Seraia, E., Ebner, D. V., & Ryan, A. J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32966 · Cited by 11
Dubois, J.-C., Bonnell, E., Filion, A. J., Frion, J., Zimmer, S., Khan, M. R., Teplitz, G. M., Casimir, L., Méthot, É., Marois, I., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2419712122 · Cited by 11
Golder, A., Nelson, L., Tighe, A., Barnes, B. M., Coulson‐Gilmer, C., Morgan, R. D., McGrail, J. C., & Taylor, S. S. (2022) · NAR Cancer · doi:10.1093/narcan/zcac036 · Cited by 12
DNA damage response regulator ATR licenses PINK1-mediated mitophagy
Marx, C., Qing, X., Gong, Y., Kirkpatrick, J. M., Siniuk, K., Beznoussenko, G. V., Kidiyoor, G. R., Kırtay, M., Buder, K., Koch, P., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf178 · Cited by 10
Patel, J. A., Rageul, J., Lo, N., Nandi, A., Zezelic, C., Lee, C., Khan, A., & Kim, H. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf573 · Cited by 9
Targeting genomic instability in cancer
Yap, T. A., Manning, H. C., Sapra, P., Mills, G. B., & O’Connor, M. J. (2026) · Cell · doi:10.1016/j.cell.2026.03.035 · Cited by 12
Kim, H., Hwang, B., Cho, S., Kim, W. J., Myung, S. C., Choi, Y. H., Kim, W., Lee, S., & Moon, S. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154794 · Cited by 9
Advances in DNA damage response inhibitors in colorectal cancer therapy
Yu, Y., Jia, H., Zhang, T., & Zhang, W. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023278 · Cited by 9
Marmolejo, C. A. O., Sanchez, C., Helms, E., McEvoy, M. J., Lee, J., Werner, M., Roberts, P. A., Hamperl, S., & Saldivar, J. C. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.01.005 · Cited by 10
Mamar, H., Fajka‐Boja, R., Mórocz, M., Jurado, E. P., Zentout, S., Mihuț, A., Kopasz, A. G., Mérey, M., Smith, R., Sharma, A. B., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae439 · Cited by 12
Targeting homologous recombination repair in cancer
Murfuni, I., & Rass, U. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803582-5.00008-5 · Cited by 8
Modeling amplified p53 responses under DNA-PK inhibition in DNA damage response
Sun, T., Li, X., & Shen, P. (2017) · Oncotarget · doi:10.18632/oncotarget.15062 · Cited by 7
Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics
Ma, S., Zhang, J., Guo, Q., Cao, C., Bao, K., Liu, L., Chen, C. D., Liu, Z., Yang, J., Yang, N., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.010 · Cited by 8
Beyaert, M., Starczewska, E., Gonzalez-Perez, A. C., Vanlangendonck, N., Saussoy, P., Tilman, G., Leener, A. D., Vekemans, M., Neste, E. V. D., & Bontemps, F. (2017) · Oncotarget · doi:10.18632/oncotarget.18144 · Cited by 9
Bhattacharya, D., Hiregange, D., & Rao, B. J. (2018) · Journal of Biosciences · doi:10.1007/s12038-018-9736-7 · Cited by 8
Oncogenic YAP sensitizes cells to CHK1 inhibition via CDK4/6 driven G1 acceleration
Gertzmann, D., Presek, C., Mattes, A. L., Sänger, M., Zoller, M., Schülein‐Völk, C., Ade, C. P., Eilers, M., & Gaubatz, S. (2025) · EMBO Reports · doi:10.1038/s44319-025-00514-5 · Cited by 8
Liu, Z., Xue, H., Wang, Z., Zhao, Y., Xu, S., & Dong, X. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.106925 · Cited by 7
DNA-PK and P38 MAPK: A Kinase Collusion in Alzheimer’s Disease?
Kanungo, J. (2017) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000232 · Cited by 7
He, R., & Zhang, Z. (2022) · BioEssays · doi:10.1002/bies.202200061 · Cited by 7
Sahadevan, M., Lee, O., Muzzio, M., Phan, B., Jacobs, L. K., Khouri, N. F., Wang, J., Hu, H., Stearns, V., & Chatterton, R. T. (2017) · Biomarkers · doi:10.1080/1354750x.2017.1293736 · Cited by 7
Classen, S., Rahlf, E., Jungwirth, J., Albers, N., Hebestreit, L. P., Zielinski, A., Poole, L., Groth, M., Koch, P., Liehr, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113363 · Cited by 7
DNA repair and replicative stress addiction in neuroblastoma
Durinck, K., & Irwin, M. S. (2024) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2024.100177 · Cited by 5
High tide or low tide: the transport and metabolism of mitochondrial nucleotides
MacVicar, T. (2025) · Biochemical Journal · doi:10.1042/bcj20253237 · Cited by 7
DNA–Protein Kinase Catalytic Subunit as a Potential Target for Pulmonary Arterial Hypertension
Yamamoto, K., Lemay, S.-E. S., Yokokawa, T., Breuils‐Bonnet, S., Salem, M., Potus, F., Provencher, S., Boucherat, O., & Bonnet, S. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0239le · Cited by 5
Nunes, C., Depestel, L., Mus, L. M., Keller, K. M., Delhaye, L., Louwagie, A., Rishfi, M., Dolman, M. E. M., Olexiouk, V., Bartenhagen, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.25.397323 · Cited by 5
A landscape of synergistic drug combinations in non-small-cell lung cancerPreprint
Nair, N. U., Greninger, P., Friedman, A. A., Amzallag, A., Cortez, E., Sahu, A. D., Lee, J. S., Dastur, A., Egan, R. K., Murchie, E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.03.447011 · Cited by 5
Self-citationReplication stress responses in human lymphocytes change sex-specifically during aging
Rall-Scharpf, M., Schlotter, D., Koch, P., Szafranski, K., Groth, M., Sahm, A., Biber, S., Castaño, B. A., Heitmeir, B., Zengerling, F., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf498 · Cited by 4
Kalitin, N. N., Savchenko, E., Samoylenkova, N. S., Koroleva, N., Александровна, Л. А., Karamysheva, A. F., & Pavlova, G. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136014 · Cited by 4
Tumour growth environment modulates Chk1 signalling pathways and Chk1 inhibitor sensitivity
Massey, A. J. (2016) · Scientific Reports · doi:10.1038/srep35874 · Cited by 4
Wang, T., Shatara, M., Liu, F., Knight, T. E., Edwards, H. J., Wang, G., Lin, H., Wang, Y., Taub, J. W., & Ge, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0076-3 · Cited by 4
Li, S., Zhao, Y., Li, Y., Shah, S. B., Shi, Y., Nguyen, T., Wang, Z., Chang, C.-Y., Ray, A., Bu, T.-H., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.02.016 · Cited by 3
DNA double-strand repair by nonhomologous end joining and its clinical relevance
Setton, J. S., Bindra, R. S., & Powell, S. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803582-5.00009-7 · Cited by 4
Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
Ramakrishnan, N., Haseljic, E., & Verma, P. (2023) · Journal of Visualized Experiments · doi:10.3791/64920 · Cited by 2
Targeting the Ataxia Telangiectasia and Rad3 Signaling Pathway to Overcome Chemoresistance in Cancer
Kwok, M., & Stanković, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813753-6.00010-x · Cited by 3
Calcium Influx Guards Replication Forks against Exonuclease 1
Simoneau, A., & Zou, L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.005 · Cited by 3
Self-citationHe, X., Sun, X., & Shao, Y. (2020) · Journal of Applied Statistics · doi:10.1080/02664763.2020.1812543 · Cited by 3
Heinst, L., Lee, K.-S., Berthold, R., Isfort, I., Wosnig, S., Kuntze, A., Häfner, S., Altvater, B., Rössig, C., Åman, P., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1152 · Cited by 2
Gatz, S. A., Bender, J. G., Pearson, A. D. J., Ortiz, M. V., Bernardi, R. J., Chesler, L., Clifford, S., Cohen‐Gogo, S., Cuesta, E. A. D. L., de Rojas, T., et al. (2026) · JCO Precision Oncology · doi:10.1200/po-25-00642 · Cited by 2
Vendetti, F. P., Pandya, P., Sclafani, C. R., Pathak, S., Buj, R., Jones, R., Ivanov, D., Aird, K. M., Sobol, R. W., & Bakkenist, C. J. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf054 · Cited by 2
A Zygotic Checkpoint for Unrepaired Lesions
Zou, L. (2016) · Cell · doi:10.1016/j.cell.2016.11.049 · Cited by 2
Self-citationShen, X., Xu, X., Guo, Y., Yang, H., He, J., & Xie, P. (2022) · Journal of General Virology · doi:10.1099/jgv.0.001813 · Cited by 2
Zou, L. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.1857 · Cited by 2
Self-citationExploiting a PAX3-FOXO1-induced synthetic lethal ATR dependency for rhabdomyosarcoma therapyPreprint
García, H. D., Bei, Y., von Stebut, J., Ibáñez, G., Imami, K., Gürgen, D., Rolff, J., Helmsauer, K., Timme, N., Bardinet, V., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.04.411413 · Cited by 2
Fork Slowing and Reversal as an Adaptive Response to Chronic ATR InhibitionPreprint
Dibitetto, D., Sanchi, A., Sanford, E. J., Lopes, M., & Smolka, M. B. (2021) · SSRN Electronic Journal · doi:10.1101/2021.05.18.444697 · Cited by 2
Replication stress tolerance and management differs between naïve and primed pluripotent cellsPreprint
Kafer, G. R., O’Connor, A. E., Rogers, S., Osteil, P., Nelson, C. B., Pickett, H. A., Tam, P., & Cesare, A. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.12.491744 · Cited by 2
Segura‐Bayona, S., Maric, M., Takaki, T., Manova, Z., Stanage, T. H., Idilli, A. I., Idilli, A. I., Hewitt, G., Machour, F. E., Millar, R., et al. (2026) · Nature Structural & Molecular Biology · doi:10.1038/s41594-026-01827-2 · Cited by 2
Targeting ATR in Cancer therapy: A drug discovery perspective
Lai, Y., Zhao, W., Wang, Y., & Zhang, L. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109707 · Cited by 1
An updated view on lagging strand DNA replication: implications for the replication stress response
Martín-Rufo, R., & Lecona, E. (2026) · Cell Cycle · doi:10.1080/15384101.2026.2646889 · Cited by 1
Tilting the balance of life and death: navigating DNA replication stress in cancer therapy
Lo, N., & Kim, H. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01745-9 · Cited by 2
Proctor, E. V., Elsawa, S. F., Walker, S. R., & Cheng, J. (2026) · BMC Cancer · doi:10.1186/s12885-026-16505-1 · Cited by 1
Replication stress in cancer: origins, consequences and therapeutic opportunities
Chen, J., & Zou, L. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00979-z · Cited by 2
Self-citationTargeting Myc-driven tumours - BETing on ATR
Muralidharan, S. V. (2016) · Cited by 1
Getting a Genomic View of DNA Replication Stress
Zou, L., & Nguyen, H. D. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.001 · Cited by 1
Self-citationTargeting the DNA Damage Response for Radiosensitization
McMillan, M. T., Lawrence, T. S., & Morgan, M. A. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_9 · Cited by 1
Chopra, S. S., Jenney, A., Palmer, A. C., Niepel, M., Chung, M., Mills, C. E., Sivakumaren, S. C., Liu, Q., Chen, J.-Y., Yapp, C., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/700625 · Cited by 1
Graziano, S., Coll-Bonfill, N., Teodoro-Castro, B., Kuppa, S., Jackson, J., Shashkova, O., Mahajan, U., Vindigni, A., Antony, E., & Gonzalo, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.22.449466 · Cited by 1
A phosphorylation code coordinating transcription condensate dynamics with DNA replicationPreprint
Marmolejo, C. A. O., Sanchez, C., Lee, J., Werner, M., Roberts, P. A., Hamperl, S., & Saldivar, J. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.10.593572 · Cited by 1
Sustained E2F-Dependent Transcription Is a Key Mechanism to Prevent Replication-Stress-Induced
Bertoli, C., Herlihy, A. E., Pennycook, B. R., & Kriston-Vizi, J. (2016)
Control of DNA Replication by ATR
Lecona, E., & Fernández-Capetillo, Ó. (2018) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-75836-7_3
Demidova, E. V., Iqbal, W., & Arora, S. (2018) · Current cancer research · doi:10.1007/978-3-319-78762-6_7
Gomez, R. O. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-25042018-163036
Chopra, S. S., Jenney, A., Palmer, A. C., Niepel, M., Mills, C. E., Sivakumaren, S. C., Liu, Q., Gray, N. S., & Sorger, P. K. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3275287
ATR Inhibitors as Potent Modulators of DNA End Resection CapacityPreprint
Dibitetto, D., Sims, J. R., Ascenção, C. F. R., Feng, K., Freire, R., & Smolka, M. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.13.905059
Ito, S. S., Nakagawa, Y., Matsubayashi, M., Sakaguchi, Y. M., Kobashigawa, S., Matsui, T. K., Nanaura, H., Nakanishi, M., Kitayoshi, F., Kikuchi, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.20.051318
Barone, G., Arora, A., Ganesh, A., Abdel-fatah, T., Moseley, P., Ali, R., Chan, S. Y. T., Savva, C., Schiavone, K., Carmell, N., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.v9i50
Kaufmann, S. H. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.728649753.793565220
Characterisation of the role of the ATR kinase homolog in L. major response to replication stress
da Silva, G. L. A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-01122022-121302
Vitorino, F. N. D. L. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2022.tde-29112022-085014
The fork restart factor PHF6 interacts with RRM2 and binds to H3K56ac marked nascent DNAPreprint
Depestel, L., Bekaert, S.-L., Sanders, E., Damme, C. V., Eggermont, A., Loontiens, S., Tilleman, L., Nieuwerburgh, F. V., Delhaye, L., Vlierberghe, P. V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.08.531704
Serra, V., Wang, A. T., Castroviejo‐Bermejo, M., Polanska, U. M., Palafox, M., Herencia-Ropero, A., Jones, G. N., Lai, Z., Armenia, J., Michopoulos, F., et al. (2023) · doi:10.1158/1078-0432.c.6532931.v1
Casimir, L., Zimmer, S., Racine-Brassard, F., Goudreau, F., Jacques, P., & Maréchal, A. (2023) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2023.111834 · Cited by 1
Linking replication stress with replication dynamics in Vicia faba root meristem cellsPreprint
Musiałek, M. W., & Rybaczek, D. (2023) · Research Square · doi:10.21203/rs.3.rs-3137592/v1
Guo, Y., Wang, J., Benedict, B., Chen, Y., van Gemert, F. P. A., Ma, X., Gao, D., Wang, H., Zhang, S., Lieftink, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829569
Guo, Y., Wang, J., Benedict, B., Chen, Y., van Gemert, F. P. A., Ma, X., Gao, D., Wang, H., Zhang, S., Lieftink, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829560
Toxicity Adaptive Lists Design: A Practical Design for Phase I Drug Combination Trials in Oncology
Russo, M., Mariani, F., Cleary, J. M., Shapiro, G. I., Cote, G. M., & Trippa, L. (2024) · JCO Precision Oncology · doi:10.1200/po.24.00275
Liu, W., Jiang, X., Ma, Y., Qing, H., Bao, Y., & Jiao, Z. (2025) · Medical Oncology · doi:10.1007/s12032-025-03053-0
Pan, Y., Yang, Y., Huang, R., Yang, H., Huang, Q., Ji, Y., Dai, J., Qiao, K., Tang, W., Xie, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26556068
Pan, Y., Yang, Y., Huang, R., Yang, H., Huang, Q., Ji, Y., Dai, J., Qiao, K., Tang, W., Xie, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26556065
Guo, Y., Wang, J., Benedict, B., Yang, C., van Gemert, F., Ma, X., Gao, D., Wang, H., Zhang, S., Lieftink, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829572
Guo, Y., Wang, J., Benedict, B., Yang, C., van Gemert, F., Ma, X., Gao, D., Wang, H., Zhang, S., Lieftink, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829566
Levy, M., Ferraro, G. B., Han, Y., Federico, G., Varricchio, L., Nandi, V., An, X., Hoffman, R., Carlomagno, F., Fretland, A. J., et al. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100075
Etude de l'effondrement rapide des fourches de réplication lors d'un stress réplicatif
de Rugy, T. G. (2016) · theses.fr (ABES) · doi:10.70675/a5dcd5aaz6bd9z4846z9da6z0dd36ab82aa0
Mutations de la voie ATR-CHK1, réponse au stress réplicatif et cancer
Egger, T. (2018) · theses.fr (ABES) · doi:10.70675/eb51eb1ezc51dz4737zaf38z954d1a68dbea
Criblage de petites molécules d'intérêt thérapeutique et recherche de leur mécanisme d'action
Rozié, A. (2020) · theses.fr (ABES) · doi:10.70675/cfe93a65zdad1z4f4fzb5e3z4c2daf8ea474
Metadata
- Authors
- Buisson, R., Boisvert, J. L., Benes, C. H., & Zou, L.
- Affiliations
- Harvard University (US)
- Corresponding author
- Zou, Lee
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 59
- Issue
- 6
- Pages
- 1011-1024
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC4575890
- OpenAlex
- W1855851918
- Cited by
- 316
- References
- 72
- Citations by year
- 2026: 27 · 2025: 14 · 2024: 16 · 2023: 27 · 2022: 33 · 2021: 37 · 2020: 38 · 2019: 30 · 2018: 38 · 2017: 29 · 2016: 25 · 2015: 2
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Wellcome Trust (102696)
- National Institute of General Medical Sciences (R01GM076388, GM076388)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- ATR, DNA-dependent protein kinase, Chk1, replication stress, S phase, DNA damage response, RRM2, replication origin firing, single-stranded DNA, replication catastrophe, cancer cell lines
- MeSH terms
- Checkpoint Kinase 1, DNA Damage, DNA Replication, DNA, Single-Stranded, Humans, Nuclear Proteins, Phosphorylation, Protein Kinases, Protein Processing, Post-Translational, Ribonucleoside Diphosphate Reductase, Stress, Physiological, S Phase, Replication Origin, Cell Line, Tumor, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review